PHARMING GROUP news, videos and press releases - Page 2
For more news please use our advanced search feature.
PHARMING GROUP - More news...
PHARMING GROUP - More news...
- Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
- Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition
- Pharming Group announces presentation of new leniolisib data at 2022 ASH Annual Meeting
- Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
- Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
- CEO of Pharming to present at H.C. Wainwright 24th Annual Global Investment Conference
- CEO of Pharming to present at H.C. Wainwright 24th Annual Global Investment Conference
- Pharming Group reports financial results for the first half of 2022
- Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
- Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS
- Pharming Group Notice of H1 2022 Results
- Pharming Group to present at Jefferies Healthcare Conference 2022
- Pharming Group: all proposals Annual General Meeting of Shareholders approved
- Pharming Group reports financial results for the first quarter of 2022
- Pharming Group Notice of Q1 2022 Results
- Pharming receives agreement of Paediatric Investigation Plan and Promising Innovative Medicine designation for leniolisib from UK MHRA
- Pharming announces change in its holding in BioConnection following a substantial investment by new investor
- Pharming announces the filing of its 2021 Annual Report, with Form 20-F also filed with the U.S. Securities and Exchange Commission and convenes its 2022 AGM
- Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting
- Pharming Group Notice of 2021 Full Year Results
- Pharming announces positive results of Phase II/III pivotal clinical study of leniolisib for the treatment of activated PI3K delta syndrome
- Pharming Group and Sanofi renew strategic manufacturing partnership agreement
- Pharming Group reports financial results for the first nine months of 2021
- Pharming Group Notice of 9M Results
- Pharming Group reports financial results for the first half of 2021
- Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedema
- Pharming Group to present at Jefferies Virtual Healthcare Conference
- Pharming Group reports financial results for the first quarter of 2021
- Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
